DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cedax (Ceftibuten Dihydrate) - Published Studies

 
 



Cedax Related Published Studies

Well-designed clinical trials related to Cedax (Ceftibuten)

Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections. [2001.09]

[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis] [2001.07.19]

Oral ceftibuten switch therapy for acute pyelonephritis in children. [2001.06]

[Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study)] [2001.06]

[Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study)] [2001.06]

Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. [2001]

Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery. [2000.11]

Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children. [2000.09.29]

Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children. [1999.12]

[Effectiveness of ceftibuten++ in the sequential therapy of respiratory and urinary tract infections] [1999.07.25]

Treatment of acute sinusitis in childhood with ceftibuten. [1999.05]

Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. [1999.03]

Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. [1998.04]

Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine. [1998.03]

Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis. [1998.01]

Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. [1998.01]

Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis. [1997.09]

Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. [1997.07]

Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers. [1997.01]

Comparative bioavailability of ceftibuten in capsule and suspension forms. [1996.11]

Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media. [1996.09]

Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. [1996.05]

Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children. [1996.05]

Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group. [1995.07]

Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group. [1995.07]

Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group. [1995.07]

The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis. [1992.12]

Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. [1992.08]

Ceftibuten versus cefaclor for the treatment of bronchitis. [1991.10]

Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children. [1991.10]

Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections. [1991.01]

Well-designed clinical trials possibly related to Cedax (Ceftibuten)

Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. [2010.04.01]

Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. [2010.04]

Treatment of lower urinary tract infection in pregnancy. [2001.04]

Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. [2000.10]

[Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy] [2000.03]

Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. [1998.12.19]

Epidemiology and treatment of otitis media with effusion in children in the first year of primary school. [1998.07]

Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics. [1988.03]

Other research related to Cedax (Ceftibuten)

Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. [2009.03]

Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. [2008.09.26]

Inhibitory effect of zinc on the absorption of beta-lactam antibiotic ceftibuten via the peptide transporters in rats. [2008]

In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens. [2007.04]

Efficacy of ceftibuten for pediatric patients undergoing adenotonsillectomy. [2000.09]

Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study. [2000.04]

Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate. [1999.06]

Clinical evaluation of ceftibuten in gonorrhea. A pilot study in Hong Kong. [1998.10]

[Therapeutic effectiveness of Cedax in the treatment of selected acute upper respiratory diseases] [1998]

Ceftibuten: a new expanded-spectrum oral cephalosporin. [1997.09]

Ceftibuten: an overview. [1997.07]

[The evaluation of ceftibuten (Cedax) effectiveness in the prevention of perioperative infections] [1997]

Ceftibuten concentrations in human tonsillar tissue. [1996.12]

[Effectiveness of and tolerance to ceftibuten in the treatment of chronic bacterial bronchitis exacerbations in an elderly population] [1996.10]

[Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten] [1996.07]

Penetration of ceftibuten into middle ear fluid. [1996.06]

[Morphological response of urinary bacteria to ceftibuten] [1996.03]

Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten. [1996.03]

Pharmacokinetics of ceftibuten in children. [1995.07]

Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs. [1995.07]

Worldwide safety experience with ceftibuten pediatric suspension. [1995.07]

Concentrations of ceftibuten in bronchial secretions. [1995.07]

Pharmacokinetics and dose proportionality of ceftibuten in men. [1995.02]

Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers. [1994.09]

Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections. [1994.05]

Liquid chromatographic determination of ceftibuten, a new oral cephalosporin, in human plasma and urine. [1994.05]

Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. [1994.05]

Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study Group. [1994.04]

Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use. [1994.03]

Impact of ceftibuten on intestinal microflora: in vitro and in vivo studies. [1994]

Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis. [1993.04]

Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study. [1993.03]

Determination of a cephalosporin antibiotic, ceftibuten, in human plasma with column-switching high-performance liquid chromatography with ultraviolet detection. [1992.07]

[In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study] [1991.05]

Treatment of acute uncomplicated urinary tract infection with ceftibuten. [1991.03]

The pharmacokinetics of ceftibuten in humans. [1991.01]

Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases. [1991.01]

Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom. [1991.01]

[Clinical studies on ceftibuten in the urinary field infection] [1990.11]

In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime. [1990.09]

[Therapeutic efficacy of ceftibuten in chronic respiratory tract infections] [1990.05]

[Clinical examination of ceftibuten in acute bronchitis] [1990.05]

Failure of ceftibuten to alter single dose theophylline clearance. [1990.05]

[Clinical studies of ceftibuten in the field of urology] [1990.02]

[Clinical studies of ceftibuten in the field of obstetrics and gynecology] [1990.01]

Other possibly related research studies

Antibiotic use profile at paediatric clinics in two transitional countries. [2004.03]

[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae] [2001.12]

Localized pustulosis induced by betalactams. [2000.05]

[Program of empirical antibacterial therapy of community-acquired pneumonia] [1998]

In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. [1998.03]

Empiric antibiotic selection criteria for respiratory infections in pediatric practice. [1997.03]

Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes. [1994.08]

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. [1994.07]

[Effect of Enterued administration on the intestinal absorption of orally active cefem antibiotics] [1994.04]

[Peroral preparations of cephalosporin antibiotics] [1994.01.03]

Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study. [1992.01]

Perioperative use of antibiotics: preventing and treating perioperative infections. [2005.11]

Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. [2004.04]

[Sensitivity of Haemophilus influenzae isolates in Spain to 17 oral antibiotics] [2003.03]

Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. [2002.07]

Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. [2001.09]

Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998. [2000.09]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017